The Prevalence and Profitability of Generic Drugs in the US Healthcare System

This chapter explores the prevalence of generic drugs in the US healthcare system, including their percentage of dispensing compared to branded drugs and the diseases commonly treated with generics. It examines the profitability of generic drug companies and the need for a balance between low prices and competition, as well as the differences in business models between generic and branded drug companies.